These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8324232)
21. Preparation of (166)Dy/(166)Ho-EDTMP: a potential in vivo generator system for bone marrow ablation. Pedraza-López M; Ferro-Flores G; de Murphy CA; Tendilla JI; Villanueva-Sánchez O Nucl Med Commun; 2004 Jun; 25(6):615-21. PubMed ID: 15167523 [TBL] [Abstract][Full Text] [Related]
22. Dosimetry considerations of bone-seeking radionuclides for marrow ablation. Bayouth JE; Macey DJ Med Phys; 1993; 20(4):1089-96. PubMed ID: 8413017 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model. Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281 [TBL] [Abstract][Full Text] [Related]
24. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. Bayouth JE; Macey DJ; Kasi LP; Fossella FV J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of newly designed phosphonate based bone-seeking agent. Srivastava P; Tiwari AK; Chadha N; Chuttani K; Mishra AK Eur J Med Chem; 2013 Jul; 65():12-20. PubMed ID: 23688696 [TBL] [Abstract][Full Text] [Related]
26. A "mix-and-use" approach for formulation of human clinical doses of Chakraborty S; Vimalnath KV; Rajeswari A; Chakravarty R; Sarma HD; Radhakrishnan E; Kamaleshwaran K; Shinto AS; Dash A J Labelled Comp Radiopharm; 2017 Jul; 60(9):410-419. PubMed ID: 28477391 [TBL] [Abstract][Full Text] [Related]
27. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Matthews DC; Appelbaum FR; Eary JF; Fisher DR; Durack LD; Bush SA; Hui TE; Martin PJ; Mitchell D; Press OW Blood; 1995 Feb; 85(4):1122-31. PubMed ID: 7849300 [TBL] [Abstract][Full Text] [Related]
28. Production, biodistribution, and dosimetry of (47)Sc-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid as a bone-seeking radiopharmaceutical. Fathi F; Moghaddam-Banaem L; Shamsaei M; Samani A; Maragheh MG J Med Phys; 2015; 40(3):156-64. PubMed ID: 26500402 [TBL] [Abstract][Full Text] [Related]
29. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis. Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S Appl Radiat Isot; 2008 Sep; 66(9):1196-205. PubMed ID: 18372188 [TBL] [Abstract][Full Text] [Related]
30. Preliminary dosimetric evaluation of (166)Ho-TTHMP for human based on biodistribution data in rats. Yousefnia H; Zolghadri S; Jalilian AR; Tajik M; Ghannadi-Maragheh M Appl Radiat Isot; 2014 Dec; 94():260-265. PubMed ID: 25255303 [TBL] [Abstract][Full Text] [Related]
31. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation. Chakraborty S; Das T; Banerjee S; Chaudhari PR; Sarma HD; Venkatesh M; Pillai MR Nucl Med Commun; 2004 Dec; 25(12):1169-76. PubMed ID: 15640774 [TBL] [Abstract][Full Text] [Related]
32. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants. Shatry AM; Jones M; Levy RB Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693 [TBL] [Abstract][Full Text] [Related]
33. Experimental validation of radiopharmaceutical absorbed dose to mineralized bone tissue. Desrosiers MF; Avila MJ; Schauer DA; Coursey BM; Parks NJ Appl Radiat Isot; 1993; 44(1-2):459-63. PubMed ID: 8386053 [TBL] [Abstract][Full Text] [Related]
34. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. Suzuki YS; Momose Y; Higashi N; Shigematsu A; Park KB; Kim YM; Kim JR; Ryu JM J Nucl Med; 1998 Dec; 39(12):2161-6. PubMed ID: 9867162 [TBL] [Abstract][Full Text] [Related]
35. Holmium-166-DTPA as a liquid source for endovascular brachytherapy. Hong YD; Park KB; Jang BS; Choi SJ; Choi SM; Kim YM Nucl Med Biol; 2002 Nov; 29(8):833-9. PubMed ID: 12453593 [TBL] [Abstract][Full Text] [Related]
36. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP. Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337 [TBL] [Abstract][Full Text] [Related]
37. Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation. Turner JH; Claringbold PG; Manning LS; O'Donoghue HL; Berger JD; Glancy RJ J Natl Cancer Inst; 1993 Sep; 85(18):1508-13. PubMed ID: 8360933 [TBL] [Abstract][Full Text] [Related]
38. Biological effects of inhaled 144CeCl3 in beagle dogs. Hahn FF; Boecker BB; Griffith WC; Muggenburg BA Radiat Res; 1997 Jan; 147(1):92-108. PubMed ID: 8989375 [TBL] [Abstract][Full Text] [Related]
39. Preparation and bioevaluation of 166Ho labelled hydroxyapatite (HA) particles for radiosynovectomy. Unni PR; Chaudhari PR; Venkatesh M; Ramamoorthy N; Pillai MR Nucl Med Biol; 2002 Feb; 29(2):199-209. PubMed ID: 11823125 [TBL] [Abstract][Full Text] [Related]
40. Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide. Lee JD; Yang WI; Lee MG; Ryu YH; Park JH; Shin KH; Kim GE; Suh CO; Seong JS; Han BH; Choi CW; Kim EH; Kim KH; Park KB Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):221-30. PubMed ID: 11926384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]